# A Study to Investigate LYL845 in Adults With Solid Tumors

> **NCT05573035** · PHASE1 · TERMINATED · sponsor: **Lyell Immunopharma, Inc.** · enrollment: 39 (actual)

## Conditions studied

- Melanoma
- Non-small Cell Lung Cancer
- Colorectal Cancer

## Interventions

- **BIOLOGICAL:** LYL845

## Key facts

- **NCT ID:** NCT05573035
- **Lead sponsor:** Lyell Immunopharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-12-19
- **Primary completion:** 2025-01-09
- **Final completion:** 2025-01-09
- **Target enrollment:** 39 (ACTUAL)
- **Why stopped:** Pipeline Reprioritization
- **Last updated:** 2025-07-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05573035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05573035, "A Study to Investigate LYL845 in Adults With Solid Tumors". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05573035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*